Do statins improve outcomes for patients with non-small cell lung cancer? A systematic review and meta-analysis protocol

INTRODUCTION: Lung cancer is the most common neoplasm and the leading cause of cancer-related death worldwide. Non-small cell lung cancer (NSCLC), accounting for 85% of all lung cancer cases, is frequently diagnosed at an advanced and metastatic stage. In addition, survival of patients with NSCLC ha...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Feng, Liu, Guangyu, Roudi, Raheleh, Huang, Qi, Swierzy, Marc, Ismail, Mahmoud, Zhao, Song, Rueckert, Jens-Carsten
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2018
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6144318/
https://www.ncbi.nlm.nih.gov/pubmed/30206083
http://dx.doi.org/10.1136/bmjopen-2018-022161

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6144318/
https://www.ncbi.nlm.nih.gov/pubmed/30206083
http://dx.doi.org/10.1136/bmjopen-2018-022161

Ejemplares similares